Irma Fredriksson

2.8k total citations
64 papers, 1.5k citations indexed

About

Irma Fredriksson is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Irma Fredriksson has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 40 papers in Cancer Research and 13 papers in Genetics. Recurrent topics in Irma Fredriksson's work include Breast Cancer Treatment Studies (35 papers), Global Cancer Incidence and Screening (19 papers) and Cancer Risks and Factors (13 papers). Irma Fredriksson is often cited by papers focused on Breast Cancer Treatment Studies (35 papers), Global Cancer Incidence and Screening (19 papers) and Cancer Risks and Factors (13 papers). Irma Fredriksson collaborates with scholars based in Sweden, United Kingdom and Norway. Irma Fredriksson's co-authors include Lars Holmberg, Jan Frisell, Henrik Lindman, Hanna Fredholm, Sonja Eaker, Anna L.V. Johansson, Mats Lambe, Jonas Bergh, Therése Andersson and Hans Garmo and has published in prestigious journals such as Nature Medicine, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Irma Fredriksson

58 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irma Fredriksson Sweden 22 946 805 281 263 231 64 1.5k
Maysa Abu‐Khalaf United States 23 986 1.0× 614 0.8× 350 1.2× 195 0.7× 129 0.6× 91 1.8k
Javaid Iqbal Canada 15 1.1k 1.1× 782 1.0× 286 1.0× 381 1.4× 430 1.9× 23 1.8k
Erin Hofstatter United States 21 812 0.9× 612 0.8× 500 1.8× 203 0.8× 463 2.0× 60 1.9k
Foluso O. Ademuyiwa United States 28 1.3k 1.3× 818 1.0× 468 1.7× 286 1.1× 503 2.2× 91 2.2k
Nils‐Olof Bengtsson Sweden 19 1.1k 1.2× 763 0.9× 436 1.6× 156 0.6× 230 1.0× 35 2.0k
Dong‐Young Noh South Korea 27 788 0.8× 791 1.0× 342 1.2× 585 2.2× 383 1.7× 52 1.8k
Kristina Lindemann Norway 25 748 0.8× 327 0.4× 452 1.6× 151 0.6× 169 0.7× 111 2.1k
Ellen Schlichting Norway 21 834 0.9× 676 0.8× 420 1.5× 224 0.9× 457 2.0× 44 1.6k
Vani Parmar India 20 847 0.9× 782 1.0× 112 0.4× 239 0.9× 159 0.7× 106 1.5k
Susanne Taucher Austria 23 1.1k 1.1× 954 1.2× 316 1.1× 456 1.7× 256 1.1× 45 1.7k

Countries citing papers authored by Irma Fredriksson

Since Specialization
Citations

This map shows the geographic impact of Irma Fredriksson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irma Fredriksson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irma Fredriksson more than expected).

Fields of papers citing papers by Irma Fredriksson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irma Fredriksson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irma Fredriksson. The network helps show where Irma Fredriksson may publish in the future.

Co-authorship network of co-authors of Irma Fredriksson

This figure shows the co-authorship network connecting the top 25 collaborators of Irma Fredriksson. A scholar is included among the top collaborators of Irma Fredriksson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irma Fredriksson. Irma Fredriksson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fredriksson, Irma, et al.. (2025). Patient experience and healthcare cost aspects of vacuum-assisted excision of breast lesions. A report from the Swedish VAE randomized clinical trial. European Journal of Radiology. 186. 112062–112062. 1 indexed citations
2.
Karsten, Maria Margarete, Linetta B. Koppert, Jonas Bergh, et al.. (2025). Benchmarking cancer outcomes in Europe: a scoping review of methodologies and case-mix adjustments. PubMed. 9. 100176–100176.
3.
Ács, Balázs, Johan Hartman, Irma Fredriksson, et al.. (2024). Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case–control study. British journal of surgery. 111(2). 2 indexed citations
4.
Strell, Carina, et al.. (2024). Use of beta-blockers in patients with ductal carcinoma in situ and risk of invasive breast cancer recurrence: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. 207(2). 293–299. 5 indexed citations
5.
Sifakis, Emmanouil G., Emelié Karlsson, Xinsong Chen, et al.. (2024). Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer. Breast Cancer Research. 26(1). 24–24. 2 indexed citations
6.
Fredriksson, Irma, et al.. (2023). Treatment utilization and effectiveness of neoadjuvant chemotherapy comparing men and women diagnosed with breast cancer: a Swedish retrospective cohort study. Breast Cancer Research and Treatment. 203(2). 235–243. 1 indexed citations
7.
Villacampa, Guillermo, Andri Papakonstantinou, Irma Fredriksson, & Alexios Matikas. (2023). Impact of Primary Breast Surgery on Overall Survival of Patients With De Novo Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. The Oncologist. 29(1). 1–7. 3 indexed citations
8.
Backman, Malin, et al.. (2023). OptiBra study, a randomized controlled trial on optimal postoperative bra support after breast cancer surgery. European Journal of Oncology Nursing. 63. 102285–102285. 3 indexed citations
9.
Wennstig, Anna-Karin, Hans Garmo, Bo Lagerqvist, et al.. (2022). Risk of coronary stenosis after adjuvant radiotherapy for breast cancer. Strahlentherapie und Onkologie. 198(7). 630–638. 11 indexed citations
10.
Garcia‐Argibay, Miguel, Hans Garmo, Johan Ahlgren, et al.. (2021). Aromatase inhibitors use and risk for cardiovascular disease in breast cancer patients: A population-based cohort study. The Breast. 59. 157–164. 28 indexed citations
11.
Johansson, Annelie, Cassia B. Trewin-Nybråten, Irma Fredriksson, et al.. (2021). 15P The combined influence of receptor subtype, grade and TN status on breast cancer survival in recently treated women with non-metastatic disease in Norway. Annals of Oncology. 32. S26–S27. 1 indexed citations
12.
Höijer, Jonas, Linnea Widman, Johan Ahlgren, et al.. (2020). Long-Term Prognostication for 20 114 Women With Small and Node-Negative Breast Cancer  (T1abN0). JNCI Cancer Spectrum. 5(1). 3 indexed citations
13.
Plym, Anna, Anna L.V. Johansson, Hannah Bower, et al.. (2020). Impact of chemotherapy, radiotherapy, and endocrine therapy on sick leave in women with early-stage breast cancer during a 5-year period: a population-based cohort study. Breast Cancer Research and Treatment. 182(3). 699–707. 10 indexed citations
14.
Wennstig, Anna-Karin, Hans Garmo, Irma Fredriksson, et al.. (2020). Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort. Breast Cancer Research. 22(1). 10–10. 32 indexed citations
15.
Johansson, Anna L.V., Caroline E. Weibull, Irma Fredriksson, & Mats Lambe. (2018). Diagnostic pathways and management in women with pregnancy-associated breast cancer (PABC): no evidence of treatment delays following a first healthcare contact. Breast Cancer Research and Treatment. 174(2). 489–503. 20 indexed citations
16.
Ekberg, Sara, Elisabet Lidbrink, Sandra Eloranta, et al.. (2018). No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study. Breast Cancer Research. 20(1). 142–142. 27 indexed citations
17.
Fredholm, Hanna, Kristina Magnusson, Linda S. Lindström, et al.. (2017). Breast cancer in young women and prognosis: How important are proliferation markers?. European Journal of Cancer. 84. 278–289. 29 indexed citations
18.
Valachis, Antonis, Hans Garmo, John Weinman, et al.. (2016). Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study. Breast Cancer Research and Treatment. 159(2). 293–303. 22 indexed citations
19.
Ma, Ran, John Lövrot, Lóránd Kis, et al.. (2015). mTOR inhibitors counteract tamoxifen-induced activation of breast cancer stem cells. Cancer Letters. 367(1). 76–87. 46 indexed citations
20.
Fredholm, Hanna, Sonja Eaker, Jan Frisell, et al.. (2009). Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment. PLoS ONE. 4(11). e7695–e7695. 356 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maysa Abu‐Khalaf Breakdown of academic impact, for papers by Javaid Iqbal Breakdown of academic impact, for papers by Erin Hofstatter Breakdown of academic impact, for papers by Foluso O. Ademuyiwa Breakdown of academic impact, for papers by Nils‐Olof Bengtsson Breakdown of academic impact, for papers by Dong‐Young Noh Breakdown of academic impact, for papers by Kristina Lindemann Breakdown of academic impact, for papers by Ellen Schlichting Breakdown of academic impact, for papers by Vani Parmar Breakdown of academic impact, for papers by Susanne Taucher
Rankless by CCL
2026